
@ShahidNShah
Femtech developer Aspira Women's Health signs with Dana Farber to license a biomarker-based ovarian cancer diagnostic, a Madrona Venture Labs spin-out adds GPT-enabled virtual agents to billing automation and Dave, an LLM oncology tool, is born. As health IT suppliers work to incorporate artificial intelligence into their products for provider operations, medical testing, patient interaction, and other use cases, innovation is accelerating. Only three businesses Aspira Women's Health, Belong.life, and Outbound AI—have introduced new AI-driven tools that assist advanced ovarian cancer diagnosis, oncology patient interaction, and billing administration, respectively. Outbound AI, a Seattle-based company launched in 2021, declared on Tuesday that it had added generative AI to its cloud-powered PayerVA Console, which "augments human talent" while lightening the workload of billing specialists. According to the business, its goal is to relieve administrative constraints throughout the healthcare revenue cycle and to provide technologies that reduce administrative costs, boost productivity, and enhance "the daily job experience."
Continue reading at healthcareitnews.com
European Union lawmakers will review draft proposals for a regulation on the European Health Data Space and healthcare leaders attending the 2023 HIMSS European Health Conference & Exhibition will …
Posted May 13, 2023 Healthcare Health Data
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Feb 21, 2025 at 1:11pm